Skip to main content
. 2019 Nov 6;4(1):pkz090. doi: 10.1093/jncics/pkz090

Table 2.

Standardized incidence ratios (SIRs) of selected cancers among World Trade Center Health Program General Responders, 2003–2013*: restricted criterion

Site Observed Expected SIR (95% CI) Median time 9/11/01 to cancer diagnosis, y
All cancer sites combined 1072 984.4 1.09 (1.02 to 1.16) 8.6
Smoking-related 300 304.9 0.98 (0.88 to 1.10) 8.9
Oral cavity and pharynx 34 35.3 0.96 (0.67 to 1.34) 8.3
Digestive system 163 180.2 0.90 (0.77 to 1.05) 8.6
 Esophagus 19 13.0 1.46 (0.88 to 2.28) 8.2
 Stomach 19 17.8 1.07 (0.64 to 1.67) 8.3
 Colon and rectum 68 84.0 0.81 (0.63 to 1.03) 7.8
 Liver and intrahepatic bile duct 24 25.2 0.95 (0.61 to 1.42) 9.2
 Pancreas 18 23.0 0.78 (0.46 to 1.24) 9.7
Nose, nasal cavity, and middle ear <5 1.14 8.5
Larynx 10 12.0 0.83 (0.40 to 1.53) 9.8
Lung and bronchus 80 96.2 0.83 (0.66 to 1.04) 9.2
Soft tissue including heart 7 7.9 0.88 (0.35 to 1.82) 5.2
Melanoma of the skin 50 43.3 1.15 (0.86 to 1.52) 8.6
Breast 47 50.3 0.94 (0.69 to 1.24) 8.8
Corpus uteri 8 9.8 0.82 (0.35 to 1.61) 9.6
Prostate 298 238.7 1.25 (1.11 to 1.40) 8.6
Testis 10 14.5 0.69 (0.33 to 1.27) 5.9
Urinary bladder 48 44.2 1.09 (0.80 to 1.44) 9.3
Kidney and renal pelvis 54 46.7 1.16 (0.87 to 1.51) 9.2
Brain and other nervous system 21 15.6 1.34 (0.83 to 2.05) 8.6
Thyroid 73 33.4 2.19 (1.71 to 2.75) 8.7
Hematological 106 100.6 1.05 (0.86 to 1.27) 8.4
 Hodgkin lymphoma 7 8.4 0.83 (0.34 to 1.72) 6.5
 Non-Hodgkin lymphoma 47 48.8 0.96 (0.71 to 1.28) 8.5
 Myeloma 12 15.0 0.80 (0.41 to 1.40) 8.3
 Leukemia 40 28.4 1.41 (1.01 to 1.92) 8.5
  CLL 12 11.1 1.08 (0.56 to 1.89) 8.7
  AML 12 7.6 1.58 (0.82 to 2.76) 8.0
Mesothelioma <5 1.25 6.5
*

Begins 6 months past member enrollment, with enrollment beginning July 2002. AML = acute myeloid leukemia; CI = confidence interval; CLL = chronic lymphocytic leukemia.

Smoking-related cancers consist of the following cancer types: oral cavity and pharynx (excluding nasopharynx), esophagus, liver, intrahepatic bile duct, pancreas, respiratory system (excluding pleura), urinary system, and acute myeloid leukemia.